Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-dose esketamine + dexmedetomidine for postoperative sleep after total knee arthroplasty in elderly patients
ChiCTR2400085253Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and dexmedetomidine in sleep disorder and postoperative pain (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Sleep quality on the night of surgery. Started Jun 2024; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
sleep disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400085253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085253.